Sanofi India Limited (SIL) announced the election of Aditya Narayan as the chairman of the board of directors.

“Sanofi India Limited is privileged to have Aditya Narayan as chairman of the board of directors”, said Dr Shailesh Ayyangar, managing director – Sanofi India Limited.

“For over 60 years, Sanofi India has played the role of a committed and responsible company by making world-class medicines accessible in India, and meeting the challenges of our nation’s growing disease burden. Sanofi India welcomes  Narayan, with his commendable track record as a corporate leader, to guide it through the emerging complexities in the Indian pharmaceutical environment,” he further added.

Commenting on his new role, Aditya Narayan, chairman, Sanofi India Limited, said, “Sanofi India Limited has a superb track record of building strong pharmaceutical brands, several of which are now household names. Its world class manufacturing facilities and ethical marketing practices enjoy a reputation for excellence in serving its growing customers in India and overseas. It is a privilege for me to have been entrusted with the role of the chairman of the board of directors of Sanofi India Limited and I look forward to the support of all its stakeholders in discharging my responsibilities.”

Aditya Narayan, 64, has rich experience in industry for over 40 years. He served ICI Limited, now Akzo Nobel India Limited, for about 30 years across diverse functions and businesses. He was its managing director during 1996-2003 and then its non-executive chairman over 2003 - 2010. Over 2005-2009, he was the president and CEO of BHP Billiton India. He has also served on a number of other boards. Presently, he is an independent director of Hindustan Unilever Limited, Linde India Limited and, Chambal Fertilizers and Chemicals Limited.